- Home
- CVR vs CRIS Comparison
CVR vs CRIS Comparison
Compare CVR & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVR
- CRIS
- Stock Information
- Founded
- CVR 1920
- CRIS 2000
- Country
- CVR United States
- CRIS United States
- Employees
- CVR N/A
- CRIS N/A
- Industry
- CVR Industrial Machinery/Components
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVR Industrials
- CRIS Health Care
- Exchange
- CVR Nasdaq
- CRIS Nasdaq
- Market Cap
- CVR 14.9M
- CRIS 13.5M
- IPO Year
- CVR N/A
- CRIS 2000
- Fundamental
- Price
- CVR $10.48
- CRIS $1.97
- Analyst Decision
- CVR
- CRIS Strong Buy
- Analyst Count
- CVR 0
- CRIS 3
- Target Price
- CVR N/A
- CRIS $21.00
- AVG Volume (30 Days)
- CVR 7.2K
- CRIS 96.3K
- Earning Date
- CVR 05-20-2025
- CRIS 05-06-2025
- Dividend Yield
- CVR 1.08%
- CRIS N/A
- EPS Growth
- CVR N/A
- CRIS N/A
- EPS
- CVR N/A
- CRIS N/A
- Revenue
- CVR $26,986,627.00
- CRIS $11,202,000.00
- Revenue This Year
- CVR N/A
- CRIS $4.67
- Revenue Next Year
- CVR N/A
- CRIS $9.77
- P/E Ratio
- CVR N/A
- CRIS N/A
- Revenue Growth
- CVR N/A
- CRIS 14.17
- 52 Week Low
- CVR $8.25
- CRIS $1.02
- 52 Week High
- CVR $22.27
- CRIS $16.93
- Technical
- Relative Strength Index (RSI)
- CVR 47.49
- CRIS 57.59
- Support Level
- CVR $8.15
- CRIS $1.97
- Resistance Level
- CVR $14.24
- CRIS $2.69
- Average True Range (ATR)
- CVR 1.41
- CRIS 0.25
- MACD
- CVR 0.12
- CRIS 0.08
- Stochastic Oscillator
- CVR 46.63
- CRIS 63.21
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment. Geographically, the majority is from the United States.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.